Comerica Securities’s Avanos Medical AVNS Stock Holding History

Comerica Securities’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-130	Closed	-$3.52K	–	548
2022 Q4	$3.52K	Buy	+130	New	+$3.18K	﹤0.01%	1177

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Comerica Securities's AVNS Position: Q1 2023 in Review

Comerica Securities sold out of Avanos Medical (AVNS) in Q1 2023, closing a stake of 130 shares — an estimated $3.52K sold.

Comerica Securities first reported a position in AVNS in Q4 2022 and held it in 1 quarter. The position peaked at $3.52K in Q4 2022. 287 funds tracked by Wall St. Rank hold AVNS as of Q1 2023.

Comerica Securities reported no remaining Avanos Medical position as of Q1 2023 after selling out during the quarter.
Comerica Securities sold 130 Avanos Medical shares in Q1 2023, an estimated $3.52K.
Comerica Securities first reported a position in Avanos Medical in Q4 2022 and held it in 1 quarter.
Comerica Securities's Avanos Medical position peaked at $3.52K in Q4 2022.
287 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.